| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alagille Syndrome | 4 | 2019 | 48 | 1.160 |
Why?
|
| Genomic Structural Variation | 4 | 2025 | 92 | 1.160 |
Why?
|
| Genome, Human | 6 | 2025 | 1331 | 1.130 |
Why?
|
| DNA Copy Number Variations | 15 | 2024 | 1032 | 0.960 |
Why?
|
| Human Genetics | 1 | 2025 | 8 | 0.940 |
Why?
|
| Mosaicism | 6 | 2024 | 249 | 0.830 |
Why?
|
| Haplotypes | 2 | 2024 | 544 | 0.800 |
Why?
|
| Polymerase Chain Reaction | 2 | 2024 | 1548 | 0.790 |
Why?
|
| Neurodevelopmental Disorders | 6 | 2024 | 560 | 0.720 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2024 | 2849 | 0.680 |
Why?
|
| Psychotic Disorders | 2 | 2019 | 150 | 0.640 |
Why?
|
| Genetic Markers | 2 | 2019 | 617 | 0.630 |
Why?
|
| Pedigree | 14 | 2023 | 1718 | 0.580 |
Why?
|
| Gene Duplication | 5 | 2024 | 369 | 0.570 |
Why?
|
| Calcium-Binding Proteins | 3 | 2015 | 333 | 0.560 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2015 | 294 | 0.550 |
Why?
|
| Comparative Genomic Hybridization | 8 | 2024 | 578 | 0.550 |
Why?
|
| Phenotype | 11 | 2024 | 4526 | 0.500 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2020 | 3351 | 0.490 |
Why?
|
| Chromosome Disorders | 1 | 2018 | 311 | 0.490 |
Why?
|
| Intellectual Disability | 5 | 2023 | 1086 | 0.480 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2015 | 41 | 0.470 |
Why?
|
| Mutation | 13 | 2022 | 6227 | 0.470 |
Why?
|
| Membrane Proteins | 4 | 2020 | 1610 | 0.450 |
Why?
|
| Exome | 6 | 2020 | 1087 | 0.440 |
Why?
|
| Bipolar Disorder | 1 | 2018 | 369 | 0.440 |
Why?
|
| Adenosine Triphosphatases | 1 | 2015 | 198 | 0.420 |
Why?
|
| Biliary Atresia | 4 | 2020 | 206 | 0.420 |
Why?
|
| Genomics | 7 | 2025 | 1647 | 0.420 |
Why?
|
| Tetralogy of Fallot | 1 | 2015 | 176 | 0.420 |
Why?
|
| Jagged-1 Protein | 4 | 2019 | 54 | 0.410 |
Why?
|
| Chromosome Mapping | 3 | 2025 | 1095 | 0.400 |
Why?
|
| Chromosome Inversion | 2 | 2024 | 78 | 0.380 |
Why?
|
| Gene Rearrangement | 4 | 2022 | 327 | 0.370 |
Why?
|
| High-Throughput Nucleotide Sequencing | 6 | 2024 | 946 | 0.370 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2024 | 120 | 0.350 |
Why?
|
| Arthrogryposis | 2 | 2022 | 39 | 0.340 |
Why?
|
| Mutation, Missense | 3 | 2020 | 935 | 0.340 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2024 | 309 | 0.330 |
Why?
|
| Chromosome Aberrations | 3 | 2024 | 589 | 0.330 |
Why?
|
| Heterozygote | 4 | 2020 | 713 | 0.330 |
Why?
|
| Humans | 51 | 2025 | 131985 | 0.320 |
Why?
|
| Heterotaxy Syndrome | 2 | 2024 | 63 | 0.320 |
Why?
|
| Urogenital Abnormalities | 2 | 2023 | 164 | 0.320 |
Why?
|
| Chromosome Duplication | 2 | 2021 | 149 | 0.300 |
Why?
|
| Microcephaly | 2 | 2023 | 351 | 0.280 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 2 | 2018 | 56 | 0.280 |
Why?
|
| Receptor, Notch2 | 2 | 2019 | 12 | 0.270 |
Why?
|
| Abnormalities, Multiple | 3 | 2022 | 981 | 0.270 |
Why?
|
| Serrate-Jagged Proteins | 3 | 2015 | 37 | 0.260 |
Why?
|
| Whole Genome Sequencing | 4 | 2024 | 327 | 0.250 |
Why?
|
| Genetic Association Studies | 5 | 2020 | 852 | 0.230 |
Why?
|
| Translocation, Genetic | 2 | 2024 | 356 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2024 | 61 | 0.220 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2024 | 357 | 0.210 |
Why?
|
| Genomic Instability | 2 | 2022 | 245 | 0.210 |
Why?
|
| Rare Diseases | 2 | 2024 | 209 | 0.210 |
Why?
|
| Gene Deletion | 2 | 2017 | 792 | 0.200 |
Why?
|
| Recombination, Genetic | 1 | 2024 | 441 | 0.200 |
Why?
|
| Genes, Dominant | 2 | 2020 | 250 | 0.200 |
Why?
|
| Male | 26 | 2024 | 64910 | 0.200 |
Why?
|
| Homologous Recombination | 2 | 2020 | 100 | 0.200 |
Why?
|
| 46, XX Disorders of Sex Development | 1 | 2023 | 26 | 0.200 |
Why?
|
| Fluorescent Dyes | 1 | 2024 | 263 | 0.190 |
Why?
|
| Transposition of Great Vessels | 1 | 2024 | 133 | 0.190 |
Why?
|
| Myokymia | 1 | 2022 | 9 | 0.190 |
Why?
|
| Female | 26 | 2024 | 70623 | 0.190 |
Why?
|
| Polydactyly | 1 | 2022 | 18 | 0.190 |
Why?
|
| Contracture | 1 | 2022 | 27 | 0.190 |
Why?
|
| Apyrase | 1 | 2022 | 21 | 0.190 |
Why?
|
| Software | 2 | 2024 | 732 | 0.190 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2022 | 40 | 0.190 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2022 | 30 | 0.190 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2023 | 257 | 0.180 |
Why?
|
| Megalencephaly | 1 | 2022 | 60 | 0.180 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2022 | 72 | 0.180 |
Why?
|
| Cation Transport Proteins | 1 | 2022 | 100 | 0.180 |
Why?
|
| Eye Abnormalities | 1 | 2022 | 104 | 0.180 |
Why?
|
| Karyotyping | 2 | 2020 | 317 | 0.180 |
Why?
|
| Alu Elements | 1 | 2021 | 67 | 0.170 |
Why?
|
| Genome-Wide Association Study | 3 | 2020 | 1828 | 0.170 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 540 | 0.170 |
Why?
|
| Neoplasms | 1 | 2015 | 2955 | 0.170 |
Why?
|
| Dishevelled Proteins | 1 | 2020 | 44 | 0.170 |
Why?
|
| DNA End-Joining Repair | 1 | 2020 | 38 | 0.170 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2020 | 36 | 0.170 |
Why?
|
| Symporters | 1 | 2021 | 77 | 0.170 |
Why?
|
| Epilepsy, Generalized | 1 | 2021 | 65 | 0.170 |
Why?
|
| Oxidoreductases | 1 | 2020 | 101 | 0.160 |
Why?
|
| Nucleotidyltransferases | 1 | 2020 | 49 | 0.160 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2020 | 81 | 0.160 |
Why?
|
| Homozygote | 4 | 2024 | 547 | 0.160 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2019 | 27 | 0.160 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2020 | 40 | 0.160 |
Why?
|
| Myosin Heavy Chains | 1 | 2020 | 70 | 0.160 |
Why?
|
| Lissencephaly | 1 | 2019 | 11 | 0.160 |
Why?
|
| Dwarfism | 1 | 2020 | 103 | 0.160 |
Why?
|
| Limb Deformities, Congenital | 1 | 2020 | 112 | 0.160 |
Why?
|
| White Matter | 1 | 2022 | 213 | 0.160 |
Why?
|
| Muscle, Smooth | 1 | 2020 | 131 | 0.160 |
Why?
|
| Glycine Dehydrogenase (Decarboxylating) | 1 | 2019 | 3 | 0.160 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2020 | 73 | 0.150 |
Why?
|
| Glycine Agents | 1 | 2019 | 10 | 0.150 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2019 | 8 | 0.150 |
Why?
|
| Heat-Shock Proteins | 1 | 2020 | 183 | 0.150 |
Why?
|
| RNA Helicases | 1 | 2019 | 69 | 0.150 |
Why?
|
| Heart Defects, Congenital | 2 | 2024 | 1861 | 0.150 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 175 | 0.150 |
Why?
|
| Craniofacial Abnormalities | 1 | 2020 | 253 | 0.150 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 159 | 0.140 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2019 | 146 | 0.140 |
Why?
|
| Mitochondrial Proteins | 1 | 2020 | 260 | 0.140 |
Why?
|
| Glycine | 1 | 2019 | 161 | 0.140 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 167 | 0.140 |
Why?
|
| Psychotropic Drugs | 1 | 2019 | 130 | 0.140 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2019 | 149 | 0.140 |
Why?
|
| Mitochondrial Diseases | 1 | 2020 | 147 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2018 | 109 | 0.140 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 152 | 0.140 |
Why?
|
| Child | 12 | 2024 | 25762 | 0.140 |
Why?
|
| Sequence Deletion | 2 | 2021 | 526 | 0.140 |
Why?
|
| DNA Mutational Analysis | 2 | 2020 | 824 | 0.130 |
Why?
|
| DNA Repair | 1 | 2020 | 565 | 0.130 |
Why?
|
| Cholesterol | 1 | 2020 | 558 | 0.130 |
Why?
|
| Risperidone | 1 | 2017 | 60 | 0.130 |
Why?
|
| Infant | 10 | 2021 | 13047 | 0.130 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2018 | 768 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 1131 | 0.120 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2020 | 456 | 0.120 |
Why?
|
| Infant, Newborn | 8 | 2023 | 8542 | 0.120 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 26 | 0.120 |
Why?
|
| Hypopituitarism | 1 | 2015 | 18 | 0.120 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2015 | 79 | 0.110 |
Why?
|
| Twins, Monozygotic | 1 | 2015 | 127 | 0.110 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 697 | 0.110 |
Why?
|
| Environment | 1 | 2015 | 148 | 0.110 |
Why?
|
| Siblings | 1 | 2015 | 202 | 0.110 |
Why?
|
| Mitochondria | 1 | 2020 | 747 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 397 | 0.110 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2015 | 223 | 0.110 |
Why?
|
| Protein Kinases | 1 | 2015 | 331 | 0.110 |
Why?
|
| Antipsychotic Agents | 1 | 2017 | 381 | 0.100 |
Why?
|
| Hypoxia | 1 | 2015 | 258 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2013 | 71 | 0.100 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2013 | 65 | 0.100 |
Why?
|
| Child, Preschool | 7 | 2024 | 14732 | 0.100 |
Why?
|
| Depressive Disorder, Major | 1 | 2018 | 441 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 4 | 2024 | 1799 | 0.100 |
Why?
|
| Genetic Variation | 1 | 2019 | 1580 | 0.100 |
Why?
|
| Atrial Fibrillation | 1 | 2020 | 758 | 0.090 |
Why?
|
| Cohort Studies | 5 | 2021 | 5166 | 0.090 |
Why?
|
| Genetic Heterogeneity | 2 | 2024 | 140 | 0.090 |
Why?
|
| Anxiety Disorders | 1 | 2018 | 720 | 0.090 |
Why?
|
| Liver Diseases | 1 | 2015 | 384 | 0.090 |
Why?
|
| Young Adult | 6 | 2021 | 9952 | 0.090 |
Why?
|
| Alleles | 3 | 2024 | 1685 | 0.090 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2015 | 326 | 0.090 |
Why?
|
| Placenta | 1 | 2015 | 538 | 0.090 |
Why?
|
| Base Sequence | 1 | 2015 | 2899 | 0.080 |
Why?
|
| DNA-Binding Proteins | 3 | 2022 | 1977 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2021 | 372 | 0.070 |
Why?
|
| Adult | 8 | 2021 | 31547 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 951 | 0.070 |
Why?
|
| Animals | 6 | 2024 | 34789 | 0.070 |
Why?
|
| Adolescent | 6 | 2021 | 20535 | 0.070 |
Why?
|
| Pan troglodytes | 1 | 2024 | 77 | 0.060 |
Why?
|
| Liver | 3 | 2018 | 1796 | 0.050 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2023 | 8 | 0.050 |
Why?
|
| Sodium-Bicarbonate Symporters | 1 | 2023 | 16 | 0.050 |
Why?
|
| Bicarbonates | 1 | 2023 | 100 | 0.050 |
Why?
|
| Sodium Bicarbonate | 1 | 2023 | 56 | 0.050 |
Why?
|
| Codon, Terminator | 1 | 2023 | 27 | 0.050 |
Why?
|
| Parents | 2 | 2020 | 1079 | 0.050 |
Why?
|
| Mullerian Ducts | 1 | 2023 | 46 | 0.050 |
Why?
|
| Qa-SNARE Proteins | 1 | 2022 | 20 | 0.050 |
Why?
|
| Iran | 1 | 2023 | 94 | 0.050 |
Why?
|
| Arteries | 1 | 2024 | 222 | 0.050 |
Why?
|
| ADAMTS Proteins | 1 | 2022 | 9 | 0.050 |
Why?
|
| Reverse Genetics | 1 | 2022 | 16 | 0.050 |
Why?
|
| Membrane Transport Proteins | 1 | 2023 | 180 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2022 | 43 | 0.050 |
Why?
|
| Sodium | 1 | 2023 | 295 | 0.050 |
Why?
|
| Nucleotides | 1 | 2022 | 89 | 0.050 |
Why?
|
| Dysarthria | 1 | 2022 | 26 | 0.050 |
Why?
|
| Consanguinity | 1 | 2022 | 121 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 85 | 0.050 |
Why?
|
| Frameshift Mutation | 1 | 2023 | 200 | 0.050 |
Why?
|
| Paraplegia | 1 | 2022 | 96 | 0.050 |
Why?
|
| Zinc | 1 | 2022 | 124 | 0.050 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 123 | 0.050 |
Why?
|
| Turkey | 1 | 2021 | 67 | 0.050 |
Why?
|
| X Chromosome Inactivation | 1 | 2021 | 64 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2022 | 2493 | 0.040 |
Why?
|
| Mice | 3 | 2023 | 18461 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 272 | 0.040 |
Why?
|
| Hedgehog Proteins | 1 | 2022 | 263 | 0.040 |
Why?
|
| Chromosomes, Human, X | 1 | 2021 | 157 | 0.040 |
Why?
|
| Peru | 1 | 2020 | 56 | 0.040 |
Why?
|
| Ataxia | 1 | 2022 | 177 | 0.040 |
Why?
|
| LIM Domain Proteins | 1 | 2020 | 65 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2024 | 624 | 0.040 |
Why?
|
| Esophageal Motility Disorders | 1 | 2020 | 22 | 0.040 |
Why?
|
| Corneal Opacity | 1 | 2020 | 22 | 0.040 |
Why?
|
| Sequence Homology | 1 | 2020 | 63 | 0.040 |
Why?
|
| Digestive System | 1 | 2020 | 65 | 0.040 |
Why?
|
| Regenerative Medicine | 1 | 2020 | 35 | 0.040 |
Why?
|
| Genes, Recessive | 1 | 2020 | 193 | 0.040 |
Why?
|
| Chromosome Breakpoints | 1 | 2019 | 83 | 0.040 |
Why?
|
| Inheritance Patterns | 1 | 2020 | 130 | 0.040 |
Why?
|
| Tubulin | 1 | 2019 | 72 | 0.040 |
Why?
|
| Congenital Abnormalities | 1 | 2023 | 299 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 571 | 0.040 |
Why?
|
| Connectin | 1 | 2019 | 29 | 0.040 |
Why?
|
| Electromyography | 1 | 2020 | 141 | 0.040 |
Why?
|
| Axons | 1 | 2022 | 390 | 0.040 |
Why?
|
| Mutation Rate | 1 | 2019 | 72 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2022 | 456 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2019 | 36 | 0.040 |
Why?
|
| Intestinal Diseases | 1 | 2020 | 76 | 0.040 |
Why?
|
| Wnt Signaling Pathway | 1 | 2020 | 205 | 0.040 |
Why?
|
| Ankyrins | 1 | 2020 | 96 | 0.040 |
Why?
|
| Gene-Environment Interaction | 1 | 2020 | 129 | 0.040 |
Why?
|
| Microtubules | 1 | 2019 | 125 | 0.040 |
Why?
|
| Gastroparesis | 1 | 2020 | 67 | 0.040 |
Why?
|
| Uterus | 1 | 2023 | 548 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 151 | 0.040 |
Why?
|
| Muscle Hypotonia | 1 | 2020 | 196 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2019 | 235 | 0.040 |
Why?
|
| Endoscopy, Digestive System | 1 | 2020 | 157 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2020 | 749 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2020 | 282 | 0.040 |
Why?
|
| Retina | 1 | 2022 | 490 | 0.040 |
Why?
|
| Cerebellum | 1 | 2022 | 462 | 0.040 |
Why?
|
| Vesicular Transport Proteins | 1 | 2019 | 122 | 0.040 |
Why?
|
| Genotyping Techniques | 1 | 2018 | 109 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 430 | 0.040 |
Why?
|
| Genotype | 2 | 2015 | 2697 | 0.040 |
Why?
|
| Proteomics | 1 | 2022 | 596 | 0.040 |
Why?
|
| Nervous System Malformations | 1 | 2019 | 131 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 604 | 0.030 |
Why?
|
| Organogenesis | 1 | 2018 | 82 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2020 | 827 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 2438 | 0.030 |
Why?
|
| Radiography | 1 | 2020 | 819 | 0.030 |
Why?
|
| Heart Atria | 1 | 2020 | 340 | 0.030 |
Why?
|
| Family | 1 | 2020 | 595 | 0.030 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 246 | 0.030 |
Why?
|
| Brain Diseases | 1 | 2020 | 305 | 0.030 |
Why?
|
| DNA | 1 | 2022 | 1473 | 0.030 |
Why?
|
| Syndrome | 1 | 2020 | 1174 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2018 | 238 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2018 | 313 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2020 | 575 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2018 | 359 | 0.030 |
Why?
|
| Middle Aged | 3 | 2021 | 28976 | 0.030 |
Why?
|
| NIMA-Related Kinases | 1 | 2015 | 13 | 0.030 |
Why?
|
| Cell Movement | 1 | 2019 | 888 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 1179 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2023 | 3860 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 2669 | 0.030 |
Why?
|
| Gene Expression | 1 | 2020 | 1558 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2019 | 1658 | 0.030 |
Why?
|
| Gestational Age | 1 | 2019 | 1224 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 518 | 0.030 |
Why?
|
| Stem Cells | 1 | 2020 | 732 | 0.030 |
Why?
|
| Pancreas | 1 | 2015 | 222 | 0.030 |
Why?
|
| Facies | 1 | 2015 | 156 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2020 | 1047 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 2658 | 0.030 |
Why?
|
| Seizures | 1 | 2020 | 893 | 0.030 |
Why?
|
| Age of Onset | 1 | 2015 | 622 | 0.030 |
Why?
|
| Aminopeptidases | 1 | 2013 | 15 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1839 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2013 | 316 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2020 | 3410 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2020 | 1960 | 0.020 |
Why?
|
| Rats | 1 | 2018 | 3608 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 1044 | 0.020 |
Why?
|
| Biopsy | 1 | 2013 | 1284 | 0.020 |
Why?
|
| Neurons | 1 | 2019 | 1998 | 0.020 |
Why?
|
| Kidney | 1 | 2015 | 1330 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 3175 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2017 | 6569 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 7543 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 13019 | 0.010 |
Why?
|
| United States | 1 | 2013 | 11653 | 0.010 |
Why?
|